These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27625556)

  • 1. Clinical Applications of Mineral Trioxide Aggregate: Report of Four Cases.
    Hegde R; Battepati PM
    Int J Clin Pediatr Dent; 2010; 3(1):43-50. PubMed ID: 27625556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment.
    Witherspoon DE; Small JC; Harris GZ
    J Am Dent Assoc; 2006 May; 137(5):610-8. PubMed ID: 16739540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis).
    El-Meligy OA; Avery DR
    Pediatr Dent; 2006; 28(5):399-404. PubMed ID: 17036703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes for 40 necrotic immature permanent incisors treated with calcium hydroxide or mineral trioxide aggregate apexification/apexogenesis.
    Lee LW; Hsieh SC; Lin YH; Huang CF; Hsiao SH; Hung WC
    J Formos Med Assoc; 2015 Feb; 114(2):139-46. PubMed ID: 25124888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study.
    Naik S; Hegde AH
    J Indian Soc Pedod Prev Dent; 2005 Mar; 23(1):13-6. PubMed ID: 15858300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.
    Nosrat A; Seifi A; Asgary S
    Int J Paediatr Dent; 2013 Jan; 23(1):56-63. PubMed ID: 22309243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apexogenesis of an Immature Permanent Molar with Irreversible Pulpitis Using Mineral Trioxide Aggregate Pulpotomy: A Case Report.
    ArakkalVettath MR; Alshehri Y; Alshehri FS; Alyeezadi M; Kumar P; Almuthhin M; Alzahrani EI; Alruwaili RHG
    J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1863-S1866. PubMed ID: 38882828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital pulp therapy with three different pulpotomy agents in immature molars: a case report.
    Harandi A; Forghani M; Ghoddusi J
    Iran Endod J; 2013; 8(3):145-8. PubMed ID: 23922578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dentine in a capsule: clinical case reports.
    Kenchappa M; Gupta S; Gupta P; Sharma P
    J Indian Soc Pedod Prev Dent; 2015; 33(3):250-4. PubMed ID: 26156282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial.
    Nair PN; Duncan HF; Pitt Ford TR; Luder HU
    Int Endod J; 2008 Feb; 41(2):128-50. PubMed ID: 17956562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulp management after traumatic injuries with a tricalcium silicate-based cement (Biodentine™): a report of two cases, up to 48 months follow-up.
    Martens L; Rajasekharan S; Cauwels R
    Eur Arch Paediatr Dent; 2015 Dec; 16(6):491-6. PubMed ID: 26026789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pulpal responses to pulpotomy and pulp capping with biodentine and mineral trioxide aggregate in dogs.
    De Rossi A; Silva LA; Gatón-Hernández P; Sousa-Neto MD; Nelson-Filho P; Silva RA; de Queiroz AM
    J Endod; 2014 Sep; 40(9):1362-9. PubMed ID: 25146016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.
    Roberts HW; Toth JM; Berzins DW; Charlton DG
    Dent Mater; 2008 Feb; 24(2):149-64. PubMed ID: 17586038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTA applications in pediatric dentistry.
    Maturo P; Costacurta M; Bartolino M; Docimo R
    Oral Implantol (Rome); 2009 Jul; 2(3):37-44. PubMed ID: 23285367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
    Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    J Endod; 2008 Jul; 34(7 Suppl):S25-8. PubMed ID: 18565368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    Pediatr Dent; 2008; 30(3):220-4. PubMed ID: 18615987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth.
    Akcay M; Sari S
    Pediatr Dent; 2014; 36(4):316-21. PubMed ID: 25197997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.